Clinical Trial Update: Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS) [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 trial evaluating alpha-lipoic acid for secondary progressive multiple sclerosis; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Chronic Progressive

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Multiple Sclerosis, Chronic Progressive | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-02-02